欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/1545/001
药品名称Oxynal 10/5mg Retardtabletten
活性成分
    • naloxone hydrochloride 5.0 mg
    • oxycodone hydrochloride 10.0 mg
剂型Prolonged-release tablet
上市许可持有人Pilot merging: The procedure was merged with DE/H/1612/001/DC Mundipharma GmbH Mundipharma Str. 2 65549 Limburg Gerrnany
参考成员国 - 产品名称Germany (DE)
互认成员国 - 产品名称
    许可日期2008/10/25
    最近更新日期2017/05/12
    药物ATC编码
      • N02AA05 oxycodone
      • V03AB15 naloxone
    申请类型
    • TypeLevel1:Known Active Substance
    • TypeLevel2:Initial Application
    • TypeLevel3:Fixed combination Art 10b Dir 2001/83/EC
    • TypeLevel4:Chemical Substance
    • TypeLevel5:Prescription Only
    附件文件下载
    市场状态Withdrawn(注:已撤市)
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase